|
Originally published In Press as doi:10.1074/jbc.M412653200 on March 23, 2005
J. Biol. Chem., Vol. 280, Issue 21, 20833-20841, May 27, 2005
Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation*
Alexandre Semov ,
Maria J. Moreno ,
Anatoli Onichtchenko ,
Abedelnasser Abulrob ,
Marguerite Ball ,
Irena Ekiel¶,
Grzegorz Pietrzynski ,
Danica Stanimirovic , and
Valery Alakhov ||
From the
Supratek Pharma Inc., Montreal, Quebec H9S 1A9, Canada, Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, K1A 0R6, Canada, and ¶Biotechnology Research Institute, National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada
Many advanced tumors overexpress and secrete the S100A4 protein that is known to promote angiogenesis and metastasis development. The mechanisms of this effect and the endothelial receptor for S100A4 are both still unknown. Here we report that extracellular S100A4 interacts with annexin II, an endothelial plasminogen co-receptor. Co-localization and direct binding of S100A4 and annexin II were demonstrated, and the binding site was identified in the N-terminal region of annexin II. S100A4 alone or in a complex with annexin II accelerated tissue plasminogen activator-mediated plasminogen activation in solution and on the endothelial cell surface through interaction of the S100A4 C-terminal lysines with the lysine-binding domains of plasminogen. A synthetic peptide corresponding to the N terminus of annexin II prevented S100A4-induced plasmin formation in the endothelial cell culture. Local plasmin formation induced by circulating S100A4 could contribute to tumor-induced angiogenesis and metastasis formation that makes this protein an attractive target for new anti-cancer and anti-angiogenic therapies.
Received for publication, November 9, 2004
, and in revised form, March 8, 2005.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: Supratek Pharma Inc., 215 Blvd. Bouchard, Suite 1315, Dorval, Quebec H9S 1A9, Canada. Tel.: 514-422-9191; Fax: 514-422-9410; E-mail: Valery.Alakhov{at}Supratek.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Yan, C. Zhou, X. Lou, Z. Xiao, H. Zhu, Q. Wang, Y. Wang, N. Lu, S. He, Q. Zhan, et al.
PTTG Overexpression Promotes Lymph Node Metastasis in Human Esophageal Squamous Cell Carcinoma
Cancer Res.,
April 15, 2009;
69(8):
3283 - 3290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Ismail, D. G. Fernig, P. S. Rudland, C. J. Terry, G. Wang, and R. Barraclough
The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis
Carcinogenesis,
December 1, 2008;
29(12):
2259 - 2266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Warren, M. Summan, X. Gao, R. Chapman, T. Hulderman, and P. P. Simeonova
Mechanisms of skeletal muscle injury and repair revealed by gene expression studies in mouse models
J. Physiol.,
July 15, 2007;
582(2):
825 - 841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schneider, S. Kostin, C. C. Strom, M. Aplin, S. Lyngbaek, J. Theilade, M. Grigorian, C. B. Andersen, E. Lukanidin, J. Lerche Hansen, et al.
S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes
Cardiovasc Res,
July 1, 2007;
75(1):
40 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Brisset, H. Hao, E. Camenzind, M. Bacchetta, A. Geinoz, J.-C. Sanchez, C. Chaponnier, G. Gabbiani, and M.-L. Bochaton-Piallat
Intimal Smooth Muscle Cells of Porcine and Human Coronary Artery Express S100A4, a Marker of the Rhomboid Phenotype In Vitro
Circ. Res.,
April 13, 2007;
100(7):
1055 - 1062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-C. Tsai, S.-T. Tsai, Y.-T. Jin, and L.-W. Wu
Cyclooxygenase-2 Is Involved in S100A2-Mediated Tumor Suppression in Squamous Cell Carcinoma
Mol. Cancer Res.,
August 1, 2006;
4(8):
539 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Garrett, K. M. Varney, D. J. Weber, and A. R. Bresnick
S100A4, a Mediator of Metastasis
J. Biol. Chem.,
January 13, 2006;
281(2):
677 - 680.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. EGEBLAD, L.E. LITTLEPAGE, and Z. WERB
The Fibroblastic Coconspirator in Cancer Progression
Cold Spring Harb Symp Quant Biol,
January 1, 2005;
70(0):
383 - 388.
[Abstract]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|